Verily CEO Stephen Gillett told staff that the company's Granular insurance business is to be acquired by Elevance Health.

Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.

Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 ...

Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, ...

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a ...

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

Verily, an Alphabet (GOOG) (GOOGL) precision health company, has agreed to sell the company’s Granular insurance business to Elevance Health ...

Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...